IDO2 and COVID-19: Recently, we showed that the otherwise rarely expressed tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase-2 (IDO2) was abundantly expressed and enzymatically active in lung, heart and brain, and also monocytes and lymphocytes of patients with fatal COVID-19.6